Work

Work Limitations and Productivity Loss Are Associated with Health-Related Quality of Life but Not with Clinical Severity in Patients with Psoriasis

Year: 2006
Type: article
Study design: Observational Study
Abstract: BACKGROUND: According to current guidelines the cost of productivity loss should be considered in pharmacoeconomic analyses. The cost of health-related productivity loss in psoriasis patients is unknown. OBJECTIVE: To estimate the cost of productivity loss in psoriasis and its association with health-related quality of life and clinical disease severity. METHODS: Cross-sectional study, recruitment of adult participants through Internet advertisements. 201 (72.3%) out of 278 eligible participants completed the study. Health-related work productivity loss, quality of life and clinical severity of psoriasis were assessed by standardized instruments. RESULTS: Indirect costs of productivity loss clearly exceed the total direct cost. In contrast to objective clinical disease severity, health-related quality of life (measured by the Dermatology Life Quality Index) is an independent predictor of work productivity. CONCLUSIONS: There is good reason to believe that intervention can reduce health-related productivity loss by improving patients' quality of life. Savings from increased work productivity might offset comparatively high acquisition costs of biological agents.
Source: Dermatology
Language: English
Subfield: Immunology
Open Access status: bronze
OpenAlex ID: W1991068078
FWCI: 3.602
Cites: 62
Cited by: 169
Related to: 10